Bracco Imaging Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-05-27
Share capital
700,000.00 PLN
Average employment (FTE)
19.9 (2025)
Registered address
Domaniewska 39A, 02-672 Warszawa, Poland

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$710,135
Profit allocationDividend and reserves
Planned capital expenditure (next year)$565,545
Foreign sales14.63% of revenue ($4,459,680)
Revenue structureSprzedaż towarów
Contingent liabilitiesYes

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 5 days late). All were audited by a statutory auditor.

  • 202502/07/2026
  • 202414/07/2025
  • 202324/06/2024
  • 202228/06/2023
  • 202120/07/2022
  • 202023/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods131 / 1,141
Top 11%
Division · Wholesale trade1,055 / 20,010
Top 5.3%
City · Warszawa1,685 / 57,023
Top 3.0%
Voivodeship · Mazowieckie2,255 / 77,210
Top 2.9%
Country · Poland7,301 / 298,279
Top 2.5%

Results vs industry

Revenue
This companyUSD 30.52mMedianUSD 1.07mAverageUSD 22.39m
Net profit
This companyUSD 2.73mMedianUSD 37.46kAverageUSD 877.59k
Operating costs
This companyUSD 26.86mMedianUSD 932.14kAverageUSD 21.07m
Assets
This companyUSD 15.70mMedianUSD 609.79kAverageUSD 11.84m

Public procurement

Bracco Imaging Polska is the contractor in 20 public sector contracts, worth USD 23.13k in total. They were signed with 17 public buyers. The largest number (2) were signed with Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie.

SubjectAmount
Technical inspection of an ACIST CVi type automatic contrast injector.
$999.46
Repair of the contrast injector for MRI EMPOWER MR BRACCO, SN: M82611. Reported fault: errors 24 and 58; the syringe cannot be used
$1,828
Diagnosis/repair of contrast injector
$999.46

Authorized Representatives

Adam Mirosław Kurzejaage 62 – Attorney-in-fact (sole)
Marco De Francesco – Management Board Member
Milic Repa – Management Board Member

Manner of representation

The company is represented by two members of the management board acting jointly; the foregoing does not limit the authority of an independent commercial proxy to represent the company independently.

Ownership

OwnerSharesShare valueStake
Bracco Imaging Holding B.v.
693$187,196.1199%
Others
7$1,890.871%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2011-07-11.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 30,675

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$11,112
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$16,513
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$11,112

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Centrala Farmaceutyczna CefarmS.A.
ITPS.A.
Synkmedsp. z o.o.
Intimexsp. z o.o. + limited partnership
IMC Impomed CentrumS.A.
Gtm-Mobil M-T T.Walisiewiczsp. k.
Reynolds Medicalsp. z o.o.
Petronafsp. z o.o.
CryoprofilS.A.
Novisc Pharmasp. z o.o.

Change history

DateEvent
2018-07-31PKD change
2014-04-14Address change
2011-05-27Entered in the register

FAQ

Last updated: 2026-10-04